SPRYD7 |
Q5W111
|
SPRY domain containing 7
|
|
2.1E-04 |
0.931 |
0.115 |
ST13P4 |
Q8IZP2
|
ST13, Hsp70 interacting protein pseudogene 4
|
|
|
0.839 |
0.154 |
IGHV3-21 |
A0A0B4J1V1
|
immunoglobulin heavy variable 3-21
|
|
|
0.780 |
0.192 |
DEL13Q14 |
|
Chromosome 13q14 deletion syndrome
|
|
|
0.805 |
0.192 |
FCRL2 |
Q96LA5
|
Fc receptor like 2
|
Cell adhesion
|
1.5E-11 |
0.861 |
0.192 |
RPS15 |
P62841
|
ribosomal protein S15
|
Nucleic acid binding
|
0.83 |
0.695 |
0.231 |
H3P31 |
|
H3 histone pseudogene 31
|
|
|
0.821 |
0.231 |
ARHGAP20 |
Q9P2F6
|
Rho GTPase activating protein 20
|
Enzyme modulator
|
2.9E-02 |
0.861 |
0.231 |
IGHV5-78 |
|
immunoglobulin heavy variable 5-78 (pseudogene)
|
|
|
0.839 |
0.231 |
CTPS1 |
P17812
|
CTP synthase 1
|
Enzyme
|
0.99 |
0.736 |
0.269 |
KCNRG |
Q8N5I3
|
potassium channel regulator
|
Enzyme modulator
|
4.1E-05 |
0.805 |
0.269 |
NTSR2 |
O95665
|
neurotensin receptor 2
|
G-protein coupled receptor
|
4.9E-03 |
0.821 |
0.269 |
NCKAP1L |
P55160
|
NCK associated protein 1 like
|
|
0.85 |
0.839 |
0.269 |
CD5 |
P06127
|
CD5 molecule
|
|
2.3E-10 |
0.682 |
0.308 |
FCRL1 |
Q96LA6
|
Fc receptor like 1
|
Cell adhesion
|
4.0E-06 |
0.751 |
0.308 |
NPAT |
Q14207
|
nuclear protein, coactivator of histone transcription
|
|
0.28 |
0.751 |
0.308 |
IGL |
|
immunoglobulin lambda locus
|
|
|
0.659 |
0.346 |
CLLS2 |
|
Disrupted in B-cell neoplasia
|
|
|
0.678 |
0.346 |
DUSP8 |
Q13202
|
dual specificity phosphatase 8
|
|
0.70 |
0.769 |
0.385 |
PTPRO |
Q16827
|
protein tyrosine phosphatase receptor type O
|
|
1.2E-05 |
0.656 |
0.423 |
LILRB4 |
Q8NHJ6
|
leukocyte immunoglobulin like receptor B4
|
Receptor
|
4.7E-13 |
0.659 |
0.423 |
PPP2R1B |
P30154
|
protein phosphatase 2 scaffold subunit Abeta
|
Enzyme
|
3.0E-15 |
0.678 |
0.423 |
IGHV3-52 |
|
immunoglobulin heavy variable 3-52 (pseudogene)
|
|
|
0.674 |
0.423 |
ARL11 |
Q969Q4
|
ADP ribosylation factor like GTPase 11
|
|
5.3E-03 |
0.670 |
0.423 |
PTP4A2 |
Q12974
|
protein tyrosine phosphatase 4A2
|
|
0.97 |
0.695 |
0.423 |